Amanote Research

Amanote Research

    RegisterSign In

The Chemosensitivity Profile of Retinoblastoma

Anti-Cancer Drugs - United States
doi 10.1097/00001813-200109000-00021
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncologyPharmacology
Date

September 1, 2001

Authors
Federica Di NicolantonioIan A. CreeMichael NealeZerrin OnadimJohn L. HungerfordJudith L. Kingston
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors

PLoS ONE
Multidisciplinary
2016English

miR‑34a Regulates the Chemosensitivity of Retinoblastoma Cells via Modulation of MAGE‑A/p53 Signaling

International Journal of Oncology
Cancer ResearchOncology
2018English

Tunisian Retinoblastoma Clinical and Genetic Profile

Acta Ophthalmologica
MedicineOphthalmology
2018English

Retinoblastoma Protein Modulates Gankyrin–MDM2 in Regulation of P53 Stability and Chemosensitivity in Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

The Epigenetic Origin of Retinoblastoma

European Ophthalmic Review
2012English

Chemosensitivity Depends on the Dependency

Journal of Cell Biology
MedicineCell Biology
2009English

Retinoblastoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

The Locus Coeruleus and Central Chemosensitivity

Respiratory Physiology and Neurobiology
NeurosciencePulmonaryRespiratory MedicinePhysiology
2010English

Retinoblastoma

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy